Clinical trials: For Participants With Advanced Solid Tumors Failed With Previous Lines of Treatment
For Participants With Advanced Solid Tumors Failed With Previous Lines of Treatment
Phase 1a/1b BGB-290 for Advanced Solid Tumors.
The study contains Phase 1A and Phase 1B. Phase 1A has Part1 (BID Dose Escalation) and Part2 (QD Dosing Escalation) Evaluation of a cohort of at least three participants completing one cycle of treatment at that dose level and…
- Trial name
- NCT02361723
- Testing
- BGB-290
- Where
- 7 sites in Australia
- Volunteers
- 101 people
- Sponsor
- BeiGene